Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 447 | 1,517 | 1,272 | 520 | 534 |
| Receivables | 1,812 | 1,559 | 2,719 | 1,839 | 1,111 |
| Other current assets | 424 | 426 | 794 | 1,402 | 1,043 |
| TOTAL | $2,748 | $3,548 | $4,855 | $3,857 | $2,726 |
| Non-Current Assets | |||||
| Investments And Advances | 32 | 32 | 32 | 32 | 32 |
| TOTAL | $32 | $32 | $32 | $32 | $32 |
| Total Assets | $2,780 | $3,580 | $4,887 | $3,889 | $2,758 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,261 | 1,552 | 2,426 | 2,394 | 1,395 |
| TOTAL | $1,702 | $1,995 | $3,251 | $3,852 | $2,480 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 441 | 443 | 825 | 1,458 | 1,085 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,702 | $1,995 | $3,251 | $3,852 | $2,480 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 135,850 | 135,850 | 134,550 | 134,550 | 134,550 |
| Common Shares | 1,359 | 1,359 | 1,346 | 1,346 | 1,346 |
| Retained earnings | -184,699 | -184,002 | -183,477 | -185,053 | -184,617 |
| Other shareholders' equity | 5 | 5 | 5 | 5 | 5 |
| TOTAL | $1,078 | $1,585 | $1,636 | $37 | $278 |
| Total Liabilities And Equity | $2,780 | $3,580 | $4,887 | $3,889 | $2,758 |